No patent protection for Stelara? No problem for J&J as Tremfya fills the void FiercePharma 16:36 Wed, 15 Jul
Celltrion wins Korea phase 1 approval for Tremfya biosimilar Korea Biomedical Review 07:47 Wed, 15 Jul
Celltrion gets green light for Phase 1 clinical trial of 'Tremfya' biosimilar in South Korea Asia Today 02:00 Wed, 15 Jul
Tremfya enters Korea’s inflammatory bowel disease reimbursement market as care shifts toward deep remission Korea Biomedical Review 06:47 Tue, 30 Jun
